Reprocessed Inquiry Steerable Diagnostic EP Catheter

{0}------------------------------------------------ Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, with the letters "FDA" in a blue square. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue. March 5, 2021 Innovative Health, LLC. Amanda Babcock Regulatory Affairs Manager 1435 North Hayden Road Suite 100 Scottsdale, Arizona 85257 Re: K203261 Trade/Device Name: Reprocessed Inquiry Steerable Diagnostic EP Catheter Regulation Number: 21 CFR 870.1220 Regulation Name: Electrode Recording Catheter Or Electrode Recording Probe Regulatory Class: Class II Product Code: DRF. NHL Dated: February 5, 2021 Received: February 8, 2021 Dear Amanda Babcock: # (NOTE: Reprocessed SUD device types require a separate attachment of the list of all models cleared in the submission. A corrected SE letter will be required if the attachment is omitted.) We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {1}------------------------------------------------ Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801 and Part 809); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems. For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100). Sincerely, Jessica Paulsen Director Division of Cardiac Electrophysiology, Diagnostics and Monitoring Devices Office of Cardiovascular Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ The following device models are included in the scope of this 510(k) submission: | Item<br>Number | Number of<br>Electrodes | French<br>Size | Electrode<br>Spacing (mm) | Curve | Usable<br>Length (cm) | |----------------|-------------------------|----------------|---------------------------|---------------|-----------------------| | 81530 | 10 | 4F | 2 | Medium | 110 | | 81531 | 10 | 4F | 2-5-2 | Medium | 110 | | 81532 | 10 | 4F | 2-5-2 | Large | 110 | | 81534 | 10 | 4F | 5 | Large | 110 | | 81537 | 10 | 4F | 25 | M(SC)(60) | 60 | | 81871 | 8 | 5F | 2 | Medium | 110 | | 81872 | 8 | 5F | 2-5-2 | Medium | 110 | | 81540 | 4 | 4F | 2-5-2 | Medium | 110 | | 81542 | 4 | 4F | 5 | Medium | 110 | | 81543 | 4 | 4F | 2-5-2 | Large | 110 | | 81472 | 4 | 5F | 2-5-2 | Medium | 110 | | 81473 | 4 | 5F | 5 | Medium | 110 | | 81474 | 4 | 5F | 2-5-2 | Large | 110 | | 81483 | 4 | 5F | 5 | E(HIS) | 110 | | 81402 | 4 | 6F | 2-5-2 | Medium | 110 | | 81403 | 4 | 6F | 5 | Medium | 110 | | 81404 | 4 | 6F | 2-5-2 | Large | 110 | | 81405 | 4 | 6F | 5 | Large | 110 | | 81417 | 4 | 6F | 5 | X-Large | 110 | | 81418 | 4 | 6F | 2-5-2 | X-Large | 110 | | 81102 | 10 | 6F | 2-5-2 | Medium | 110 | | 81104 | 10 | 6F | 2-5-2 | Large | 110 | | 81105 | 10 | 6F | 2-5-2 | X-Large | 110 | | 81107 | 10 | 6F | 5 | Large | 110 | | 81520 | 10 | 6F | 2 | X-Large | 110 | | 81524 | 10 | 6F | 2 | Large | 110 | | 81945 | 10 | 6F | 2-5-2 | Large | 110 | | 81947 | 10 | 6F | 5 | Medium/ Large | 110 | | 81504 | 10 | 6F | 5 | Medium | 110 | | 81801 | 8 | 6F | 2 | Medium | 110 | | 81802 | 8 | 6F | 2-5-2 | Medium | 110 | | 81807 | 8 | 6F | 2 | Large | 110 | | 81809 | 8 | 6F | 2-5-2 | Large | 110 | | 81516 | 8 | 6F | 2-5-2 | L1 | 110 | | 81171 | 10 | 5F | 2 | Medium | 110 | | 81172 | 10 | 5F | 2-5-2 | Medium | 110 | | 81174 | 10 | 5F | 2-5-2 | Large | 110 | | 81223 | 10 | 5F | 2-50-3 | X-Large | 110 | | 81224 | 10 | 5F | 2-30-3 | Medium | 110 | | 81202 | 20 | 7F | 2-10-2 | XX-Large | 110 | | 81207 | 20 | 7F | 5 | Super Large | 110 | | 81209 | 20 | 7F | 2-5-2 | Super Large | 110 | {3}------------------------------------------------ # Indications for Use 510(k) Number (if known) K203261 Device Name Reprocessed Inquiry Steerable Diagnostic Electrophysiology (EP) Catheter Indications for Use (Describe) The Reprocessed Inquiry Steerable Diagnostic Electrophysiology Catheters are used for electrogram recording and cardiac stimulation during diagnostic electrophysiology studies. The catheters are commonly placed at the hight atrium, right ventricular apex, and HIS bundle. | Type of Use (Select one or both, as applicable) | | |---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------| | <span style="text-decoration: underline;"><b></b></span> <span style="text-decoration: overline;"><b></b></span> <input checked="" type="checkbox"/> Prescription Use (Part 21 CFR 801 Subpart D) | <input type="checkbox"/> Over The Counter Use (21 CFR 801) | | X Prescription Use (Part 21 CFR 801 Subpart D) __ Over-The-Counter Use (21 CFR 801 Subpart C) ### CONTINUE ON A SEPARATE PAGE IF NEEDED. This section applies only to requirements of the Paperwork Reduction Act of 1995. #### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.* The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to: > Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov "An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number." {4}------------------------------------------------ ## SECTION 5: 510(k) SUMMARY As required by 21 CFR 807.92(c) ### Submitter's Name and Address: Innovative Health, LLC. 1435 N. Hayden Road, Suite 100 Scottsdale, AZ 85257 ### Contact Name and Information: Amanda Babcock Regulatory Affairs Manager Innovative Health, LLC. (480) 525-5911 (office) (888) 965-7705 (fax) ababcock@innovative-health.com ### Date prepared: November 4, 2020 ### Device Information: | Trade/Proprietary Name: | Reprocessed Inquiry Steerable Diagnostic<br>Electrophysiology Catheters | |-------------------------|-------------------------------------------------------------------------| | Common Name: | Diagnostic Electrophysiology Catheter | | Classification Name: | Catheter, Recording, Electrode, Reprocessed | | Classification Number: | Class II, 21 CFR 870.1220 | | Product Code: | NLH | ### Predicate Device: | 510(k) Number | 510(k) Title | Manufacturer | |---------------|-----------------------------------------------------------------------------|-------------------------| | K171277 | Reprocessed Inquiry Steerable<br>Diagnostic EP Catheter | Innovative Health, LLC. | | K982232 | Modification of the IBI-1100 Steerable<br>Electrophysiology Catheter System | Irvine Biomedical, Inc. | | K961924 | IBI-1100 Steerable Electrophysiology<br>Catheter System | Irvine Biomedical, Inc. | #### Device Description: The Reprocessed Inquiry Steerable Diagnostic Electrophysiology Catheters are flexible, insulated catheters constructed of thermoplastic elastomer material and noble metal electrodes. The tip of the steerable catheters may be manipulated with the control mechanism located in the handle of the proximal end of the catheter. {5}------------------------------------------------ | Item<br>Number | Number of<br>Electrodes | French<br>Size | Electrode<br>Spacing (mm) | Curve | Usable<br>Length (cm) | |----------------|-------------------------|----------------|---------------------------|---------------|-----------------------| | 81530 | 10 | 4F | 2 | Medium | 110 | | 81531 | 10 | 4F | 2-5-2 | Medium | 110 | | 81532 | 10 | 4F | 2-5-2 | Large | 110 | | 81534 | 10 | 4F | 5 | Large | 110 | | 81537 | 10 | 4F | 25 | M(SC)(60) | 60 | | 81871 | 8 | 5F | 2 | Medium | 110 | | 81872 | 8 | 5F | 2-5-2 | Medium | 110 | | 81540 | 4 | 4F | 2-5-2 | Medium | 110 | | 81542 | 4 | 4F | 5 | Medium | 110 | | 81543 | 4 | 4F | 2-5-2 | Large | 110 | | 81472 | 4 | 5F | 2-5-2 | Medium | 110 | | 81473 | 4 | 5F | 5 | Medium | 110 | | 81474 | 4 | 5F | 2-5-2 | Large | 110 | | 81483 | 4 | 5F | 5 | E(HIS) | 110 | | 81402 | 4 | 6F | 2-5-2 | Medium | 110 | | 81403 | 4 | 6F | 5 | Medium | 110 | | 81404 | 4 | 6F | 2-5-2 | Large | 110 | | 81405 | 4 | 6F | 5 | Large | 110 | | 81417 | 4 | 6F | 5 | X-Large | 110 | | 81418 | 4 | 6F | 2-5-2 | X-Large | 110 | | 81102 | 10 | 6F | 2-5-2 | Medium | 110 | | 81104 | 10 | 6F | 2-5-2 | Large | 110 | | 81105 | 10 | 6F | 2-5-2 | X-Large | 110 | | 81107 | 10 | 6F | 5 | Large | 110 | | 81520 | 10 | 6F | 2 | X-Large | 110 | | 81524 | 10 | 6F | 2 | Large | 110 | | 81945 | 10 | 6F | 2-5-2 | Large | 110 | | 81947 | 10 | 6F | 5 | Medium/ Large | 110 | | 81504 | 10 | 6F | 5 | Medium | 110 | | 81801 | 8 | 6F | 2 | Medium | 110 | | 81802 | 8 | 6F | 2-5-2 | Medium | 110 | | 81807 | 8 | 6F | 2 | Large | 110 | | 81809 | 8 | 6F | 2-5-2 | Large | 110 | | 81516 | 8 | 6F | 2-5-2 | L1 | 110 | | 81171 | 10 | 5F | 2 | Medium | 110 | | 81172 | 10 | 5F | 2-5-2 | Medium | 110 | | 81174 | 10 | 5F | 2-5-2 | Large | 110 | | 81223 | 10 | 5F | 2-50-3 | X-Large | 110 | | 81224 | 10 | 5F | 2-30-3 | Medium | 110 | | ltem<br>Number | Number of<br>Electrodes | French<br>Size | Electrode<br>Spacing (mm) | Curve | Usable<br>Length (cm) | | 81202 | 20 | 7F | 2-10-2 | XX-Large | 110 | | 81207 | 20 | 7F | 5 | Super Large | 110 | | 81209 | 20 | 7F | 2-5-2 | Super Large | 110 | The item numbers included in the scope of this submission are as follows: {6}------------------------------------------------ Table 1: Item Numbers in Scope This 510(k) increases the Reprocessing Cycles for the devices cleared under K171277 from one (1) to three (3). ## Indications for Use: The Reprocessed Inquiry Steerable Diagnostic Electrophysiology Catheters are used for electrogram recording and cardiac stimulation during diagnostic electrophysiology studies. The catheters are commonly placed at the high right atrium, right ventricular apex, and HIS bundle. ## Technological Characteristics: The purpose, design, materials, function, and intended use of the Reprocessed Inquiry Steerable Diagnostic Electrophysiology (EP) Catheters are identical to the predicate devices. There are no changes to the claims, clinical applications, patient population, performance specifications, or method of operation. In addition, Innovative Health's reprocessing of these devices includes removal of visible soil and decontamination. Each device is inspected and function tested prior to packaging and labeling. ## Functional and Safety Testing: Bench and laboratory testing was conducted to demonstrate performance (safety and effectiveness) of the Reprocessed Inquiry Steerable Diagnostic EP Catheter for three (3) reprocessing cycles. This included the following: - Biocompatibility ● - Cleaning Validation ● - Sterilization Validation ● - Functional Testing ● - Visual Inspection ● - Dimensional Verification ● - Electrical Continuity and Resistance ● - Simulated Use - Mechanical Characteristics . - Electrical Safety Testing . - Dielectric and Current Leakage . - Packaging Validation . The Reprocessed Inquiry Steerable Diagnostic EP Catheters are reprocessed no more than three (3) times. Each device is marked and tracked. After the device has reached the maximum number of reprocessing cycles, the device is rejected from further reprocessing. Reprocessing is performed only by Innovative Health. Innovative Health restricts its reprocessing to exclude devices previously reprocessed by other reprocessors. {7}------------------------------------------------ ## Predicate Comparison: A comparison of the device and reprocessing methods with the predicates are provided in the table below: | | K203261 | K171277 | K982232 | K961924 | |-------------------------|----------------------------------------------------------------------------------|------------------------------|-----------|-----------| | Device: | Identical | Identical | Identical | Identical | | Reprocessing<br>Cycles: | 3 | 1 | 0 | 0 | | Reprocessing<br>Method: | Change to processing<br>parameters and method.<br>Shelf life change. | Cleared/validated<br>process | N/A | N/A | | Sterilization: | Change to release<br>method. No change to the<br>sterilization method or<br>SAL. | Cleared/validated<br>process | N/A | N/A | | Routine<br>Monitoring: | Change to frequency and<br>adjustment of limits. | Cleared process | N/A | N/A | ### Conclusion: Innovative Health concludes that the Reprocessed Inquiry Steerable Diagnostic EP Catheters are as safe and effective as the predicate devices described herein.